Reproductive Health in Men and Women With Vasculitis

Sponsor
University of South Florida (Other)
Overall Status
Completed
CT.gov ID
NCT02176070
Collaborator
Duke University (Other), Boston University (Other), Data Management and Coordinating Center (DMCC) (Other)
467
1
12.9
36.1

Study Details

Study Description

Brief Summary

The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis.

Detailed Description

All patients enrolled in the Vasculitis Clinical Research Consortium's Contact Registry were invited via email to participate in this study. The Contract Registry includes people who self-identify as having one of 6 vasculitities: Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosum, Takayasu's Arteritis, and Giant Cell Arteritis. People voluntarily enroll in this Registry with the understanding that they will receive information about clinical studies for which they might be eligible. The introductory email included basic information about the study and all of the required elements for informed consent in a brief format. By clicking the link to the reproductive health questionnaire, participants gave their consent to be included in the study.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
467 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Reproductive Health in Men and Women With Vasculitis
Study Start Date :
Feb 1, 2011
Actual Primary Completion Date :
Mar 1, 2012
Actual Study Completion Date :
Mar 1, 2012

Outcome Measures

Primary Outcome Measures

  1. The rate of infertility with and without prior cyc. [1 year after the study is closed to enrollment]

Secondary Outcome Measures

  1. The rate of pregnancy complications in pregnancies delivered before and after vasculitis diagnosis. [1 year after the study is closed to enrollment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Enrolled in VCRC Contact Registry

  • Patient reported diagnosis of Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosa, Takayasu's Arteritis, Giant Cell Arteritis, Behcet's Disease, Kawasaki Disease, Henoch-Schoenlein Purpura, CNS or Drug-induced Vasculitis

  • 18 years of age or older

  • English speaking

Exclusion Criteria:
  • Inability to provide informed consent and complete survey

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of South Florida Data Management Coordinating Center Tampa Florida United States 33612

Sponsors and Collaborators

  • University of South Florida
  • Duke University
  • Boston University
  • Data Management and Coordinating Center (DMCC)

Investigators

  • Study Chair: Megan Clowse, MD, MPH, Duke University
  • Study Chair: Amanda M. Terry, MA, USF College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Florida
ClinicalTrials.gov Identifier:
NCT02176070
Other Study ID Numbers:
  • 5531
First Posted:
Jun 26, 2014
Last Update Posted:
Jun 26, 2014
Last Verified:
Jun 1, 2014

Study Results

No Results Posted as of Jun 26, 2014